Treatment Updates in MDS
ASCO® 2023 Insights: "Efficacy and Safety Results From the Ph3 COMMANDS Trial - Evaluating Luspatercept vs. Epoetin Alfa in ESA‑Naïve Transfusion-Dependent Pts With LR-MDS"
Login to view comments.
Click here to Login
Treatment Updates in MDS